Tweenvest Stocks

Hunan Hansen Pharmaceutical Co., Ltd. (SZSE: 002412)

Health Care · Pharmaceuticals · CN

CN¥10.19

+39.21% today · +46.2% 1Y

Hunan Hansen Pharmaceutical Co., Ltd. (SZSE: 002412) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $762.76M and employs 2,108 people.

Over the last twelve months the share price has gained 46.2%, trading between 5.32 and 10.19.

Tweenvest scores Hunan Hansen Pharmaceutical Co., Ltd. across four factors: quality 80/100, value 57/100, growth 50/100, dividend 91/100. Its strongest factor is dividend.

002412 price history

Not enough price history to draw a chart yet.

Key figures

Market cap
$762.76M
Revenue (TTM)
$149.72M
P/E
22.77
EPS
0.45
Dividend yield
2.94%
Beta (5Y)
0.29
52-week high
CN¥10.19
52-week low
CN¥5.32
Avg volume (3M)
Shares outstanding
503.20M
Employees
2,108
Next earnings

About Hunan Hansen Pharmaceutical Co., Ltd.

Hunan Hansen Pharmaceutical Co., Ltd. is engaged in the manufacturing and global distribution of a wide array of both traditional Chinese and Western pharmaceutical products. The company's diverse offerings are available in numerous formats, including injectables, oral liquids, tablets, capsules, granules, syrups, decoctions, tinctures, and pills. Its primary operational base is located in Yiyang, China.

ISIN
CNE100000PK2
Founded
1998
Listed since
May 25, 2010
Exchange
Shenzhen Stock Exchange
Currency
CNY
CompanyMarket capPriceDay
Eli Lilly and CompanyNYSE: LLY$1.12T$1,257.35+0.16%
Johnson & JohnsonNYSE: JNJ$651.25B$271.37+0.42%
Merck & Co., Inc.NYSE: MRK$376.37B$152.55+2.39%
Roche Holding AGSWX: ROP$373.91BCHF370.90-1.25%
Novartis AGSWX: NOVN$302.17BCHF127.42+0.85%
AstraZeneca PLCLSE: AZN$258.76B£121.48-0.76%
Novo Nordisk A/SCPSE: NOVO B$207.84BDkr300.85+1.59%
Pfizer Inc.NYSE: PFE$159.99B$28.15+0.29%

Browse every Pharmaceuticals company →

Figures last refreshed Aug 18, 2026.